September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The AI in cancer immunotherapy drugs market reached USD 3.52 billion in 2026, featuring leading AI in cancer immunotherapy drugs market companies such as Exscientia, Insilico Medicine.
July 2026
The global drug discovery outsourcing market size was valued at USD 4.45 billion in 2025 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
September 2026
The cancer immunotherapy market size is calculated at USD 151.26 billion in 2026 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
September 2026
The drug discovery services market size was estimated at USD 27.89 billion in 2026 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
September 2026
The biomarker discovery outsourcing services market reached USD 20.82 billion in 2026, featuring leading biomarker discovery outsourcing services market companies such as Eurofins Scientific, Charles River Laboratories, ICON plc.
September 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
September 2026
The ovarian cancer drugs market reached USD 4.36 billion in 2026, with prominent companies such as AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (GSK) (UK), AbbVie Inc. (USA), Merck & Co., Inc. (USA) leading the ovarian cancer drugs market.
September 2026
The computational medicine and drug discovery software market size reached USD 12.94 billion in 2026, with leading computational medicine and drug discovery software market companies including Entelos Inc., Crown Bioscience Inc., Chemical Computing Group Inc., Nimbus Therapeutics Inc.
September 2026
The U.S. drug discovery market generated USD 28.66 billion in 2026, with prominent U.S. drug discovery market companies including Johnson and Johnson, Pfizer Inc., Merck and Co.
September 2026
The CNS drug discovery market was valued at USD 10.86 billion in 2026, with leading companies including Eli Lilly and Company, Roche, Novartis, Pfizer, AbbVie.
September 2026
The drug discovery informatics market size stood at USD 5.35 billion in 2026, with major drug discovery informatics companies including collaborative drug discovery inc, eurofins discoverx products, jubilant biosys, selvita, novo informatics pvt ltd.
August 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
August 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
April 2026
The global liver cancer drug market size is evaluated at USD 4.39 billion in 2025 and is predicted to hit around USD 22.35 billion by 2035, growing at a CAGR of 17.67%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
March 2026
The global kidney cancer drugs market size is calculated at USD 7.24 billion in 2025 and is projected to hit around USD 12.16 billion by 2035 with a CAGR of 5.32%.
February 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.04 billion in 2025 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
December 2025
The global cancer supportive care drugs market size is projected to hit around USD 27.45 billion by 2035 from USD 22.31 billion in 2025 with a CAGR of 2.09%.
November 2025
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 6.93 billion in 2025 with a solid CAGR of 9.90%.
August 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
September 2026
The pharma 4.0 market was valued at USD 23.16 billion in 2026, with leading companies including Matthews Specialty Vehicles, Farber Specialty Vehicles, Medical Coaches.
September 2026
The quantum computing in healthcare market was valued at USD 414.14 million in 2026, with leading companies including IBM, Microsoft, Google.
September 2026
The fetal bovine serum market was valued at USD 2.73 billion in 2026, with leading companies including TCS Biosciences Ltd, Merck KGaA, Gemini Bio-Products.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com